AWM
ZBH icon

Abound Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Abound Wealth Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87 Sell
1
-29
-97% -$2.54K ﹤0.01% 1310
2026
Q1 		$2.71K Sell
30
-160
-84% -$14.7K ﹤0.01% 856
2025
Q4 		$17.1K Buy
190
+10
+6% +$948 ﹤0.01% 396
2025
Q3 		$17.7K Hold
180
– – ﹤0.01% 384
2025
Q2 		$16.4K Hold
180
– – ﹤0.01% 363
2025
Q1 		$20.4K Sell
180
-2
-1% -$214 0.01% 291
2024
Q4 		$19.2K Buy
182
+2
+1% +$215 0.01% 285
2024
Q3 		$19.4K Buy
180
+1
+0.6% +$109 0.01% 300
2024
Q2 		$19.4K Sell
179
-19
-10% -$2.24K 0.01% 253
2024
Q1 		$26.1K Buy
198
+19
+11% +$2.37K 0.01% 204
2023
Q4 		$21.8K Sell
179
-4
-2% -$446 0.01% 236
2023
Q3 		$20.5K Buy
183
+45
+33% +$5.71K 0.01% 218
2023
Q2 		$20.1K Buy
138
+109
+376% +$14.8K 0.01% 217
2023
Q1 		$3.75K Hold
29
– – ﹤0.01% 476
2022
Q4 		$3.7K Buy
29
+9
+45% +$1.04K ﹤0.01% 410
2022
Q3 		$2.09K Buy
+20
New +$2.19K ﹤0.01% 476

Other funds holding ZBH

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
QAM
QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
NCM
Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Abound Wealth Management's ZBH Position: Q2 2026 in Review

Abound Wealth Management reduced its Zimmer Biomet (ZBH) stake by 97% in Q2 2026, selling an estimated $2.54K and leaving 1 share worth $87. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

Abound Wealth Management first reported a position in ZBH in Q3 2022 and has held it in 16 quarters since. The position peaked at $26.1K in Q1 2024. 145 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Abound Wealth Management held 1 share of Zimmer Biomet worth $87 as of Q2 2026.
  • Abound Wealth Management sold 29 Zimmer Biomet shares in Q2 2026, an estimated $2.54K.
  • Zimmer Biomet made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1310 holding.
  • Abound Wealth Management first reported a position in Zimmer Biomet in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Zimmer Biomet position peaked at $26.1K in Q1 2024.
  • 145 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.